Neil Bacon, an advocate for empowering patients, has become president, CEO of non-profit dedicated to measuring patient outcomes

At the Euroscience Open Forum conference, a Bulgarian medical start-up demonstrates the potential - and the challenges - of getting health systems to focus on preventing disease, rather than responding when it strikes

High consumption rates and the widespread use of broad-spectrum antibiotics is worrying, and ‘Romania is at a cross-roads’ says the European Centre for Disease Prevention and Control.

An app developed by Google’s AI company saves nurses two hours a day. But so far it is free to use. An independent panel says DeepMind must clarify the business model, a stark illustration that as healthcare AI goes mainstream, the matter of who does what with patient data is coming into sharper focus

It is crucial to incorporate patient perspectives on healthcare innovation and decision making to increase the sustainability of Europe’s healthcare systems. A panel held at the Science|Business annual conference looked at the role Horizon Europe can play in achieving this  

Funding science and providing incentives to spur innovation in antibiotics is crucial, but political support for stewardship and prevention of inappropriate use is just as important in ensuring availability of effective and affordable drugs that are used in a responsible way

Patients are getting more access and control over their health records, but for now there are no plans to systematically collect data on outcomes

There’s huge variation around Europe in healthcare. Experts convened by Science|Business over the past two years offer explanations – and solutions

As Austria’s EU Presidency approaches, health official Clemens Auer says it’s time to stop the pilots and let digital health fly

The era of prescription digital health has dawned with approval of an app assessed to the same standard of clinical evidence as a conventional drug. Now pharma companies and digital therapy pioneers are forging development and marketing deals, while EU regulators and payers flounder

Automated surveillance was 100% accurate, while experts relying on manual recording and interpretation of individual patient data made errors. The automated system is faster and can be programmed to run checks at any timea

Using anonymised information from electronic health records is an efficient and low-cost way of following up subjects years after the treatment phase of a study completes